Yasin Keshvargar
Lawyers
Filters
Solid Biosciences $143.75 million follow-on equity offering
We advised the joint book-running managers on the stock offering
European Biotech Acquisition $120 million IPO
We advised European Biotech Acquisition, a SPAC, on its IPO and Nasdaq listing
Jounce Therapeutics $64.7 million follow-on offering
We advised the underwriters on the equity offering
Shake Shack $250 million convertible senior notes offering
We advised the initial purchasers on the Rule 144A convertible notes offering
InflaRx $75 million follow-on offering
We advised the underwriters on the equity offering
Adtalem $800 million notes offering
We advised the initial purchasers on the high-yield notes offering
Ayala Pharmaceuticals $25 million private placement
We advised the placement agent on the private placement of stock and warrants
loanDepot $62 million IPO
The shares are listed on the New York Stock Exchange
Immunocore $297 million IPO
We advised the joint book-running managers and underwriters on the IPO and Nasdaq listing
Terns Pharmaceuticals $127.5 million IPO
We advised the underwriters on the IPO and Nasdaq listing